Glycaemic trajectory and predictors of suboptimal glycaemic control in people with type 2 diabetes
Nipuni P Pathiraja1, Peter G Colman1,2, John M Wentworth1,2
1Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Insights
Identifying patients with type 2 diabetes who may not reach blood sugar targets is crucial. Factors like higher baseline HbA1c, certain medications, weight, and poor adherence predict poor glycemic control.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Management
Background:
- Type 2 diabetes requires ongoing management to prevent complications.
- Glycemic control is a key indicator of treatment effectiveness.
- Identifying factors predicting suboptimal control is essential for personalized care.
Purpose of the Study:
- To describe the glycemic trajectory in type 2 diabetes patients.
- To identify characteristics associated with suboptimal glycemic control (HbA1c targets).
Main Methods:
- Retrospective analysis of patient data from a type 2 diabetes clinic.
- Assessment of glycosylated hemoglobin (HbA1c) levels at baseline and 1 year.
- Statistical analysis to determine factors associated with higher HbA1c at 1 year.
Main Results:
- Higher baseline HbA1c predicted higher HbA1c at 1 year.
- Concurrent use of antidepressant or antipsychotic medication was associated with poorer control.
- Higher body weight and low treatment adherence were also linked to suboptimal glycemic outcomes.
Conclusions:
- Baseline HbA1c, specific medications, body weight, and adherence are key predictors of glycemic control in type 2 diabetes.
- These factors can help identify patients needing alternative care models.
- Proactive identification may improve patient outcomes and resource allocation.
Abstract:
We aimed to describe the glycaemic trajectory and define characteristics associated with suboptimal glycaemic control in the type 2 diabetes clinic. Higher glycosylated haemoglobin (HbA1c) at 1 year was associated with higher baseline HbA1c, concurrent anti-depressant or antipsychotic medication, higher bodyweight and low treatment adherence. These characteristics may help identify patients unlikely to attain HbA1c treatment targets and be better served by a different model of care.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...


